Clinical trial

Study to Evaluate Safety and Efficacy of IBsolvMIR in Islet Transplantation

NCT03867851

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2021-02-08

PhasePHASE2

Study timeline

Study start (actual)2021-02-08Date precision: day

Registry last updated2024-05-16

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetes Mellitus, Type 1unresolved

Interventions

IBsolvMIRDRUG

HeparinDRUG · verified · RxNorm: heparin

Sponsors & collaborators

TikoMed ABlead sponsor

Mapped research locations

StockholmSweden1 GothenburgSweden1 OsloNorway1 UppsalaSweden1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03867851 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.